Laboratorio Reig Jofre, S.A.

BME:RJF.D Voorraadrapport

Marktkapitalisatie: €217.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Laboratorio Reig Jofre Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Laboratorio Reig Jofre has a total shareholder equity of €188.5M and total debt of €47.4M, which brings its debt-to-equity ratio to 25.1%. Its total assets and total liabilities are €325.0M and €136.5M respectively. Laboratorio Reig Jofre's EBIT is €9.3M making its interest coverage ratio 14.7. It has cash and short-term investments of €6.0M.

Belangrijke informatie

25.1%

Verhouding schuld/eigen vermogen

€47.40m

Schuld

Rente dekkingsratio14.7x
Contant€6.04m
Aandelen€188.51m
Totaal verplichtingen€136.46m
Totaal activa€324.98m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Geen updates

Analyse van de financiële positie

Kortlopende schulden: RJF.D's short term assets (€108.8M) exceed its short term liabilities (€74.9M).

Langlopende schulden: RJF.D's short term assets (€108.8M) exceed its long term liabilities (€61.5M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RJF.D's net debt to equity ratio (21.9%) is considered satisfactory.

Schuld verminderen: RJF.D's debt to equity ratio has increased from 18.5% to 25.1% over the past 5 years.

Schuldendekking: RJF.D's debt is well covered by operating cash flow (30.6%).

Rentedekking: RJF.D's interest payments on its debt are well covered by EBIT (14.7x coverage).


Balans


Ontdek gezonde bedrijven